Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
- Status
- TERMINATED
- Phase
- PHASE1
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
- Status
- COMPLETED
- Phase
- N/A
A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Intensification With Temozolomide in Adults With a Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
- Status
- COMPLETED
- Phase
- NA
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
- Status
- COMPLETED
- Phase
- NA
Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma
- Status
- COMPLETED
- Phase
- PHASE1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
- Status
- TERMINATED
- Phase
- N/A
OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1